Docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy for patients with cervical esophageal cancer: a single-center retrospective study. View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-04-09

AUTHORS

Makoto Sakai, Makoto Sohda, Hideyuki Saito, Kengo Kuriyama, Tomonori Yoshida, Yuji Kumakura, Keigo Hara, Takehiko Yokobori, Tatsuya Miyazaki, Kazutoshi Murata, Shin-Ei Noda, Takashi Nakano, Hiroyuki Kuwano, Ken Shirabe

ABSTRACT

BACKGROUND: To evaluate the efficacy of docetaxel, cisplatin, and 5-fluorouracil as combination chemoradiotherapy (DCF-RT) for cervical esophageal cancer (CEC), we performed a retrospective analysis of CEC patients treated by DCF-RT at a single institution. METHODS: We conducted a single-center retrospective study. Twenty-one patients with CEC who underwent DCF-RT between 1999 and 2017 at our institute were included in this study. Chemotherapy consisted of intravenous docetaxel at 50 mg/m2 on day 1, intravenous CDDP at 60 mg/m2 on day 1, and intravenous 5-FU at 600 mg/m2 on days 1-4, repeated every 4 weeks for two cycles. Among the 21 patients, six were irradiated using three-dimensional conformal RT (3D- conformal RT) and 15 were treated using intensity-modulated RT (IMRT) consisting of 60 Gy in 30 fractions. RESULTS: The median follow-up period was 49.6 months (range 4.6-97.6). The overall complete response (CR) and local CR rates were 61.9% and 81.0% for all patients, and 76.9% and 84.6% for patients without hypopharyngeal and/or thoracic esophageal invasion, respectively. The 3-year overall survival (OS), progression-free survival (PFS), and local failure-free survival (LFFS) rates were 79.6, 52.4, and 74.7%, respectively. Grade 3-4 leucopenia developed in 12 patients (70.6%), neutropenia developed in 13 patients (81.2%), and mucositis developed in 2 patients (9.5%). There were no treatment-related deaths. CONCLUSIONS: The 3-year OS and LFFS of patients who underwent DCF-RT were higher than those in the previous studies. Although the high rate of myelosuppression requires careful management, DCF-RT is a safe and effective modality for CEC. More... »

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00280-019-03835-0

DOI

http://dx.doi.org/10.1007/s00280-019-03835-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1113356162

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30972455


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Gunma University", 
          "id": "https://www.grid.ac/institutes/grid.256642.1", 
          "name": [
            "Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sakai", 
        "givenName": "Makoto", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gunma University", 
          "id": "https://www.grid.ac/institutes/grid.256642.1", 
          "name": [
            "Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan. msohda@gunma-u.ac.jp."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sohda", 
        "givenName": "Makoto", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gunma University", 
          "id": "https://www.grid.ac/institutes/grid.256642.1", 
          "name": [
            "Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Saito", 
        "givenName": "Hideyuki", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gunma University", 
          "id": "https://www.grid.ac/institutes/grid.256642.1", 
          "name": [
            "Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kuriyama", 
        "givenName": "Kengo", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gunma University", 
          "id": "https://www.grid.ac/institutes/grid.256642.1", 
          "name": [
            "Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yoshida", 
        "givenName": "Tomonori", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gunma University", 
          "id": "https://www.grid.ac/institutes/grid.256642.1", 
          "name": [
            "Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kumakura", 
        "givenName": "Yuji", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gunma University", 
          "id": "https://www.grid.ac/institutes/grid.256642.1", 
          "name": [
            "Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hara", 
        "givenName": "Keigo", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gunma University", 
          "id": "https://www.grid.ac/institutes/grid.256642.1", 
          "name": [
            "Department of Innovative Cancer Immunotherapy, Gunma University Graduate School of Medicine, Maebashi, Japan."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yokobori", 
        "givenName": "Takehiko", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gunma University", 
          "id": "https://www.grid.ac/institutes/grid.256642.1", 
          "name": [
            "Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Miyazaki", 
        "givenName": "Tatsuya", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gunma University", 
          "id": "https://www.grid.ac/institutes/grid.256642.1", 
          "name": [
            "Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Murata", 
        "givenName": "Kazutoshi", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Saitama Medical University", 
          "id": "https://www.grid.ac/institutes/grid.410802.f", 
          "name": [
            "Department of Radiation Oncology, International Medical Center, Saitama Medical University, Saitama, Japan."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Noda", 
        "givenName": "Shin-Ei", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gunma University", 
          "id": "https://www.grid.ac/institutes/grid.256642.1", 
          "name": [
            "Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nakano", 
        "givenName": "Takashi", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Fukuoka City Hospital", 
          "id": "https://www.grid.ac/institutes/grid.470140.6", 
          "name": [
            "Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan.", 
            "Fukuoka City Hospital, Fukuoka, Japan."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kuwano", 
        "givenName": "Hiroyuki", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gunma University", 
          "id": "https://www.grid.ac/institutes/grid.256642.1", 
          "name": [
            "Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shirabe", 
        "givenName": "Ken", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1002/hed.23572", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000071768"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/02841860600609768", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007402699"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1053-4296(05)80066-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009739930"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-014-2659-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016064118", 
          "https://doi.org/10.1007/s00280-014-2659-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2007.10.022", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020821809"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2016.08.045", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024381351"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2016.08.045", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024381351"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.clon.2004.09.013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026490737"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10388-014-0465-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030904357", 
          "https://doi.org/10.1007/s10388-014-0465-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jjco/hyt048", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032057192"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0167-8140(00)00258-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032750803"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10388-016-0556-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038261709", 
          "https://doi.org/10.1007/s10388-016-0556-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10388-016-0556-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038261709", 
          "https://doi.org/10.1007/s10388-016-0556-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jjco/hyh107", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038717226"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.radonc.2015.07.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040822454"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2014.03.030", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046379110"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.6004/jnccn.2015.0028", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079045018"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.6004/jnccn.2015.0028", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079045018"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2002.20.5.1167", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083941966"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.18632/oncotarget.15665", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084372793"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.18632/oncotarget.15665", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084372793"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/hed.24909", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091977800"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7150/jca.23456", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1106130003"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-04-09", 
    "datePublishedReg": "2019-04-09", 
    "description": "BACKGROUND: To evaluate the efficacy of docetaxel, cisplatin, and 5-fluorouracil as combination chemoradiotherapy (DCF-RT) for cervical esophageal cancer (CEC), we performed a retrospective analysis of CEC patients treated by DCF-RT at a single institution.\nMETHODS: We conducted a single-center retrospective study. Twenty-one patients with CEC who underwent DCF-RT between 1999 and 2017 at our institute were included in this study. Chemotherapy consisted of intravenous docetaxel at 50\u00a0mg/m2 on day 1, intravenous CDDP at 60\u00a0mg/m2 on day 1, and intravenous 5-FU at 600\u00a0mg/m2 on days 1-4, repeated every 4\u00a0weeks for two cycles. Among the 21 patients, six were irradiated using three-dimensional conformal RT (3D- conformal RT) and 15 were treated using intensity-modulated RT (IMRT) consisting of 60\u00a0Gy in 30 fractions.\nRESULTS: The median follow-up period was 49.6\u00a0months (range 4.6-97.6). The overall complete response (CR) and local CR rates were 61.9% and 81.0% for all patients, and 76.9% and 84.6% for patients without hypopharyngeal and/or thoracic esophageal invasion, respectively. The 3-year overall survival (OS), progression-free survival (PFS), and local failure-free survival (LFFS) rates were 79.6, 52.4, and 74.7%, respectively. Grade 3-4 leucopenia developed in 12 patients (70.6%), neutropenia developed in 13 patients (81.2%), and mucositis developed in 2 patients (9.5%). There were no treatment-related deaths.\nCONCLUSIONS: The 3-year OS and LFFS of patients who underwent DCF-RT were higher than those in the previous studies. Although the high rate of myelosuppression requires careful management, DCF-RT is a safe and effective modality for CEC.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00280-019-03835-0", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1088364", 
        "issn": [
          "0344-5704", 
          "1432-0843"
        ], 
        "name": "Cancer Chemotherapy and Pharmacology", 
        "type": "Periodical"
      }
    ], 
    "name": "Docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy for patients with cervical esophageal cancer: a single-center retrospective study.", 
    "productId": [
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00280-019-03835-0"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1113356162"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7806519"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30972455"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00280-019-03835-0", 
      "https://app.dimensions.ai/details/publication/pub.1113356162"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-15T09:24", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000376_0000000376/records_56190_00000006.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s00280-019-03835-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00280-019-03835-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00280-019-03835-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00280-019-03835-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00280-019-03835-0'


 

This table displays all metadata directly associated to this object as RDF triples.

205 TRIPLES      20 PREDICATES      43 URIs      16 LITERALS      6 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00280-019-03835-0 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author Nc17561204abb47f489c15a705e06c77b
4 schema:citation sg:pub.10.1007/s00280-014-2659-6
5 sg:pub.10.1007/s10388-014-0465-1
6 sg:pub.10.1007/s10388-016-0556-2
7 https://doi.org/10.1002/hed.23572
8 https://doi.org/10.1002/hed.24909
9 https://doi.org/10.1016/j.clon.2004.09.013
10 https://doi.org/10.1016/j.ijrobp.2007.10.022
11 https://doi.org/10.1016/j.ijrobp.2014.03.030
12 https://doi.org/10.1016/j.ijrobp.2016.08.045
13 https://doi.org/10.1016/j.radonc.2015.07.011
14 https://doi.org/10.1016/s0167-8140(00)00258-9
15 https://doi.org/10.1016/s1053-4296(05)80066-9
16 https://doi.org/10.1080/02841860600609768
17 https://doi.org/10.1093/jjco/hyh107
18 https://doi.org/10.1093/jjco/hyt048
19 https://doi.org/10.1200/jco.2002.20.5.1167
20 https://doi.org/10.18632/oncotarget.15665
21 https://doi.org/10.6004/jnccn.2015.0028
22 https://doi.org/10.7150/jca.23456
23 schema:datePublished 2019-04-09
24 schema:datePublishedReg 2019-04-09
25 schema:description BACKGROUND: To evaluate the efficacy of docetaxel, cisplatin, and 5-fluorouracil as combination chemoradiotherapy (DCF-RT) for cervical esophageal cancer (CEC), we performed a retrospective analysis of CEC patients treated by DCF-RT at a single institution. METHODS: We conducted a single-center retrospective study. Twenty-one patients with CEC who underwent DCF-RT between 1999 and 2017 at our institute were included in this study. Chemotherapy consisted of intravenous docetaxel at 50 mg/m2 on day 1, intravenous CDDP at 60 mg/m2 on day 1, and intravenous 5-FU at 600 mg/m2 on days 1-4, repeated every 4 weeks for two cycles. Among the 21 patients, six were irradiated using three-dimensional conformal RT (3D- conformal RT) and 15 were treated using intensity-modulated RT (IMRT) consisting of 60 Gy in 30 fractions. RESULTS: The median follow-up period was 49.6 months (range 4.6-97.6). The overall complete response (CR) and local CR rates were 61.9% and 81.0% for all patients, and 76.9% and 84.6% for patients without hypopharyngeal and/or thoracic esophageal invasion, respectively. The 3-year overall survival (OS), progression-free survival (PFS), and local failure-free survival (LFFS) rates were 79.6, 52.4, and 74.7%, respectively. Grade 3-4 leucopenia developed in 12 patients (70.6%), neutropenia developed in 13 patients (81.2%), and mucositis developed in 2 patients (9.5%). There were no treatment-related deaths. CONCLUSIONS: The 3-year OS and LFFS of patients who underwent DCF-RT were higher than those in the previous studies. Although the high rate of myelosuppression requires careful management, DCF-RT is a safe and effective modality for CEC.
26 schema:genre research_article
27 schema:inLanguage en
28 schema:isAccessibleForFree false
29 schema:isPartOf sg:journal.1088364
30 schema:name Docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy for patients with cervical esophageal cancer: a single-center retrospective study.
31 schema:productId N44dd8459a29b4c02b9c2f509af98e2a9
32 N783abdddd0154665b16ec95d3afa556a
33 N9c48f0a8a6324cc696efb2ef1f59f614
34 Nb83f12a31dc949c4a1b343a8ade74cad
35 schema:sameAs https://app.dimensions.ai/details/publication/pub.1113356162
36 https://doi.org/10.1007/s00280-019-03835-0
37 schema:sdDatePublished 2019-04-15T09:24
38 schema:sdLicense https://scigraph.springernature.com/explorer/license/
39 schema:sdPublisher N8f933b3137c94f04a12f36f3a7e27d7f
40 schema:url http://link.springer.com/10.1007/s00280-019-03835-0
41 sgo:license sg:explorer/license/
42 sgo:sdDataset articles
43 rdf:type schema:ScholarlyArticle
44 N00b319c2c68843ebb85a8be515cf0466 rdf:first N0eddb1023285427c9a2634c7fb155b1f
45 rdf:rest Nf8d8be349dba4773a76e5f0632c8093d
46 N0eddb1023285427c9a2634c7fb155b1f schema:affiliation https://www.grid.ac/institutes/grid.470140.6
47 schema:familyName Kuwano
48 schema:givenName Hiroyuki
49 rdf:type schema:Person
50 N214709c060494cca97cf9442e79c090e rdf:first N248671bcc07440a59fa5a9012ac56ca4
51 rdf:rest N46b13e4a9f6c416491269b5ac1810d56
52 N248671bcc07440a59fa5a9012ac56ca4 schema:affiliation https://www.grid.ac/institutes/grid.256642.1
53 schema:familyName Kuriyama
54 schema:givenName Kengo
55 rdf:type schema:Person
56 N42471886f2234c1780d2ba4408f69e41 schema:affiliation https://www.grid.ac/institutes/grid.256642.1
57 schema:familyName Yokobori
58 schema:givenName Takehiko
59 rdf:type schema:Person
60 N44dd8459a29b4c02b9c2f509af98e2a9 schema:name pubmed_id
61 schema:value 30972455
62 rdf:type schema:PropertyValue
63 N46b13e4a9f6c416491269b5ac1810d56 rdf:first N9f5c1da5a1ce4573a0d3dcebf3e2423f
64 rdf:rest Nbe1c8889d05a4d249a0047713c8af238
65 N60faa67a13eb4747bc145b008a697ea5 schema:affiliation https://www.grid.ac/institutes/grid.256642.1
66 schema:familyName Miyazaki
67 schema:givenName Tatsuya
68 rdf:type schema:Person
69 N7743f3a424b94fae8946bd6443718e99 rdf:first Ndc0e7e65190443edbca3c12a7a426324
70 rdf:rest N00b319c2c68843ebb85a8be515cf0466
71 N783abdddd0154665b16ec95d3afa556a schema:name nlm_unique_id
72 schema:value 7806519
73 rdf:type schema:PropertyValue
74 N89abeb72ab164ca5b23045e83055bbd6 rdf:first Nb4879cc9b2a847e98ce0d82ace1b429b
75 rdf:rest Nd8b5bb696f354d64ade0469453a777aa
76 N8c1fb929b50e4e93ae9f2eccb87b46b9 rdf:first N42471886f2234c1780d2ba4408f69e41
77 rdf:rest Ne2698c2df237446c8437efe702dbf20d
78 N8ee1104fbad74b1ba8b9080b32d20e7e rdf:first Na09ed730433248a4a10b6ad48e52ebc6
79 rdf:rest N8c1fb929b50e4e93ae9f2eccb87b46b9
80 N8f933b3137c94f04a12f36f3a7e27d7f schema:name Springer Nature - SN SciGraph project
81 rdf:type schema:Organization
82 N923326aeef61491ab02b389cb4db89a6 schema:affiliation https://www.grid.ac/institutes/grid.256642.1
83 schema:familyName Sohda
84 schema:givenName Makoto
85 rdf:type schema:Person
86 N93f2b0e908be4ea7a0de77cb75e5e447 rdf:first Nccd4cc9db94c4b4eab0983fcb0528b97
87 rdf:rest N214709c060494cca97cf9442e79c090e
88 N9bbd42d30ecb4539a9603c6dad896ad7 schema:affiliation https://www.grid.ac/institutes/grid.256642.1
89 schema:familyName Sakai
90 schema:givenName Makoto
91 rdf:type schema:Person
92 N9c48f0a8a6324cc696efb2ef1f59f614 schema:name doi
93 schema:value 10.1007/s00280-019-03835-0
94 rdf:type schema:PropertyValue
95 N9f5c1da5a1ce4573a0d3dcebf3e2423f schema:affiliation https://www.grid.ac/institutes/grid.256642.1
96 schema:familyName Yoshida
97 schema:givenName Tomonori
98 rdf:type schema:Person
99 Na09ed730433248a4a10b6ad48e52ebc6 schema:affiliation https://www.grid.ac/institutes/grid.256642.1
100 schema:familyName Hara
101 schema:givenName Keigo
102 rdf:type schema:Person
103 Nb4879cc9b2a847e98ce0d82ace1b429b schema:affiliation https://www.grid.ac/institutes/grid.256642.1
104 schema:familyName Murata
105 schema:givenName Kazutoshi
106 rdf:type schema:Person
107 Nb83f12a31dc949c4a1b343a8ade74cad schema:name dimensions_id
108 schema:value pub.1113356162
109 rdf:type schema:PropertyValue
110 Nbe1c8889d05a4d249a0047713c8af238 rdf:first Ncb8ed45106dc49219494227049c63d79
111 rdf:rest N8ee1104fbad74b1ba8b9080b32d20e7e
112 Nc17561204abb47f489c15a705e06c77b rdf:first N9bbd42d30ecb4539a9603c6dad896ad7
113 rdf:rest Ne8b9d2cc87ec4b698b87ea92ab56c6de
114 Ncb8ed45106dc49219494227049c63d79 schema:affiliation https://www.grid.ac/institutes/grid.256642.1
115 schema:familyName Kumakura
116 schema:givenName Yuji
117 rdf:type schema:Person
118 Nccd4cc9db94c4b4eab0983fcb0528b97 schema:affiliation https://www.grid.ac/institutes/grid.256642.1
119 schema:familyName Saito
120 schema:givenName Hideyuki
121 rdf:type schema:Person
122 Nd8b5bb696f354d64ade0469453a777aa rdf:first Nebc4266c62fc451e87d8ac343c88cbcb
123 rdf:rest N7743f3a424b94fae8946bd6443718e99
124 Ndc0e7e65190443edbca3c12a7a426324 schema:affiliation https://www.grid.ac/institutes/grid.256642.1
125 schema:familyName Nakano
126 schema:givenName Takashi
127 rdf:type schema:Person
128 Ne2698c2df237446c8437efe702dbf20d rdf:first N60faa67a13eb4747bc145b008a697ea5
129 rdf:rest N89abeb72ab164ca5b23045e83055bbd6
130 Ne8b9d2cc87ec4b698b87ea92ab56c6de rdf:first N923326aeef61491ab02b389cb4db89a6
131 rdf:rest N93f2b0e908be4ea7a0de77cb75e5e447
132 Ne9654bec7f234d2d9f1971d96639acbc schema:affiliation https://www.grid.ac/institutes/grid.256642.1
133 schema:familyName Shirabe
134 schema:givenName Ken
135 rdf:type schema:Person
136 Nebc4266c62fc451e87d8ac343c88cbcb schema:affiliation https://www.grid.ac/institutes/grid.410802.f
137 schema:familyName Noda
138 schema:givenName Shin-Ei
139 rdf:type schema:Person
140 Nf8d8be349dba4773a76e5f0632c8093d rdf:first Ne9654bec7f234d2d9f1971d96639acbc
141 rdf:rest rdf:nil
142 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
143 schema:name Medical and Health Sciences
144 rdf:type schema:DefinedTerm
145 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
146 schema:name Oncology and Carcinogenesis
147 rdf:type schema:DefinedTerm
148 sg:journal.1088364 schema:issn 0344-5704
149 1432-0843
150 schema:name Cancer Chemotherapy and Pharmacology
151 rdf:type schema:Periodical
152 sg:pub.10.1007/s00280-014-2659-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016064118
153 https://doi.org/10.1007/s00280-014-2659-6
154 rdf:type schema:CreativeWork
155 sg:pub.10.1007/s10388-014-0465-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030904357
156 https://doi.org/10.1007/s10388-014-0465-1
157 rdf:type schema:CreativeWork
158 sg:pub.10.1007/s10388-016-0556-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038261709
159 https://doi.org/10.1007/s10388-016-0556-2
160 rdf:type schema:CreativeWork
161 https://doi.org/10.1002/hed.23572 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000071768
162 rdf:type schema:CreativeWork
163 https://doi.org/10.1002/hed.24909 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091977800
164 rdf:type schema:CreativeWork
165 https://doi.org/10.1016/j.clon.2004.09.013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026490737
166 rdf:type schema:CreativeWork
167 https://doi.org/10.1016/j.ijrobp.2007.10.022 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020821809
168 rdf:type schema:CreativeWork
169 https://doi.org/10.1016/j.ijrobp.2014.03.030 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046379110
170 rdf:type schema:CreativeWork
171 https://doi.org/10.1016/j.ijrobp.2016.08.045 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024381351
172 rdf:type schema:CreativeWork
173 https://doi.org/10.1016/j.radonc.2015.07.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040822454
174 rdf:type schema:CreativeWork
175 https://doi.org/10.1016/s0167-8140(00)00258-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032750803
176 rdf:type schema:CreativeWork
177 https://doi.org/10.1016/s1053-4296(05)80066-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009739930
178 rdf:type schema:CreativeWork
179 https://doi.org/10.1080/02841860600609768 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007402699
180 rdf:type schema:CreativeWork
181 https://doi.org/10.1093/jjco/hyh107 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038717226
182 rdf:type schema:CreativeWork
183 https://doi.org/10.1093/jjco/hyt048 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032057192
184 rdf:type schema:CreativeWork
185 https://doi.org/10.1200/jco.2002.20.5.1167 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083941966
186 rdf:type schema:CreativeWork
187 https://doi.org/10.18632/oncotarget.15665 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084372793
188 rdf:type schema:CreativeWork
189 https://doi.org/10.6004/jnccn.2015.0028 schema:sameAs https://app.dimensions.ai/details/publication/pub.1079045018
190 rdf:type schema:CreativeWork
191 https://doi.org/10.7150/jca.23456 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106130003
192 rdf:type schema:CreativeWork
193 https://www.grid.ac/institutes/grid.256642.1 schema:alternateName Gunma University
194 schema:name Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan.
195 Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan. msohda@gunma-u.ac.jp.
196 Department of Innovative Cancer Immunotherapy, Gunma University Graduate School of Medicine, Maebashi, Japan.
197 Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan.
198 rdf:type schema:Organization
199 https://www.grid.ac/institutes/grid.410802.f schema:alternateName Saitama Medical University
200 schema:name Department of Radiation Oncology, International Medical Center, Saitama Medical University, Saitama, Japan.
201 rdf:type schema:Organization
202 https://www.grid.ac/institutes/grid.470140.6 schema:alternateName Fukuoka City Hospital
203 schema:name Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan.
204 Fukuoka City Hospital, Fukuoka, Japan.
205 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...